These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12184055)

  • 1. The renin-angiotensin system in progression, remission and regression of chronic nephropathies.
    Aros C; Remuzzi G
    J Hypertens Suppl; 2002 Jun; 20(3):S45-53. PubMed ID: 12184055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.
    Remuzzi G; Ruggenenti P; Perico N
    Ann Intern Med; 2002 Apr; 136(8):604-15. PubMed ID: 11955029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of protein traffic in the progression of renal diseases.
    Ruggenenti P; Remuzzi G
    Annu Rev Med; 2000; 51():315-27. PubMed ID: 10774467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F; Rangoonwala B
    Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of cardio-renal protection in non-diabetic chronic nephropathies.
    Ruggenenti P; Remuzzi G
    Rocz Akad Med Bialymst; 2004; 49():116-23. PubMed ID: 15631326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of increased glomerular protein traffic in the progression of renal failure.
    Bruzzi I; Benigni A; Remuzzi G
    Kidney Int Suppl; 1997 Nov; 62():S29-31. PubMed ID: 9350674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular protein trafficking and progression of renal disease to terminal uremia.
    Benigni A; Remuzzi G
    Semin Nephrol; 1996 May; 16(3):151-9. PubMed ID: 8734458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
    Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of chronic kidney disease: can it be prevented or arrested?
    Jaber BL; Madias NE
    Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of diabetic renal disease: focus on losartan.
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Burns KD
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"].
    Tislér A
    Orv Hetil; 2003 May; 144(18 Suppl 1):898-901. PubMed ID: 12785234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.